142 related articles for article (PubMed ID: 25339620)
1. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival.
Patel K; Foster NR; Kumar A; Grudem M; Longenbach S; Bakkum-Gamez J; Haddock M; Dowdy S; Jatoi A
Support Care Cancer; 2015 May; 23(5):1303-9. PubMed ID: 25339620
[TBL] [Abstract][Full Text] [Related]
2. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
Dhani FK; Daryanto B; Seputra KP
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2641-2646. PubMed ID: 37642049
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydronephrosis on survival in advanced stage cervical cancer.
Goklu MR; Seckin KD; Togrul C; Goklu Y; Tahaoglu AE; Oz M; Ertas IE
Asian Pac J Cancer Prev; 2015; 16(10):4219-22. PubMed ID: 26028076
[TBL] [Abstract][Full Text] [Related]
4. Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.
Pradhan TS; Duan H; Katsoulakis E; Salame G; Lee YC; Abulafia O
Int J Gynecol Cancer; 2011 Aug; 21(6):1091-6. PubMed ID: 21738045
[TBL] [Abstract][Full Text] [Related]
5. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
6. Pelvic radiotherapy in patients with hydronephrosis in stage IIIB cancer of the cervix: renal effects and the optimal timing for urinary diversion?
Horan G; McArdle O; Martin J; Collins CD; Faul C
Gynecol Oncol; 2006 Jun; 101(3):441-4. PubMed ID: 16337996
[TBL] [Abstract][Full Text] [Related]
7. Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study.
Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
Gynecol Oncol; 2010 May; 117(2):270-5. PubMed ID: 20181381
[TBL] [Abstract][Full Text] [Related]
8. Hydronephrosis in patients with cervical cancer is an indicator of poor outcome: A nationwide population-based retrospective cohort study.
Yang YR; Chen SJ; Yen PY; Huang CP; Chiu LT; Lin WC; Chen HY; Chen YH; Chen WC
Medicine (Baltimore); 2021 Feb; 100(6):e24182. PubMed ID: 33578522
[TBL] [Abstract][Full Text] [Related]
9. [Hydronephrosis as a prognostic factor for patients of figo IIIB cervical cancer].
Krynicki R; Bidziński M; Wierzba W; Panek G; Jońska J; Lindner B
Ginekol Pol; 2003 Jan; 74(1):32-9. PubMed ID: 12715435
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
11. Impact of palliative urinary diversion by percutaneous nephrostomy drainage and ureteral stenting among patients with advanced cervical cancer and obstructive uropathy: a prospective cohort.
Lapitan MC; Buckley BS
J Obstet Gynaecol Res; 2011 Aug; 37(8):1061-70. PubMed ID: 21481096
[TBL] [Abstract][Full Text] [Related]
12. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.
Tan S; Tao Z; Bian X; Zhao Y; Wang N; Chen X; Wu B
Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():99-103. PubMed ID: 31484100
[TBL] [Abstract][Full Text] [Related]
13. The clinical implications of hydronephrosis and the level of ureteral obstruction in stage IIIB cervical cancer.
Chao KS; Leung WM; Grigsby PW; Mutch DG; Herzog T; Perez CA
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1095-100. PubMed ID: 9539564
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of hydronephrosis in the treatment of patients with locally advanced cervical cancer: a retrospective cohort.
Nóbrega L; Zanon JR; Andrade CEEMDC; Schmidt RL; Dos Santos MH; Dos Reis R
Int J Gynecol Cancer; 2022 Aug; 32(9):1123-8. PubMed ID: 35973739
[TBL] [Abstract][Full Text] [Related]
15. Tumor hypoxia, p53, and prognosis in cervical cancers.
Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of hydronephrosis in bladder cancer treated by radical cystectomy.
Lin HY; Wang SZ; Chen JX; Chen LW; Xiao J
Urologia; 2011; 78(1):17-21. PubMed ID: 21452155
[TBL] [Abstract][Full Text] [Related]
17. Passive ileal segment urinary diversion in advanced cervical carcinoma--a retrospective review.
Ngotho D; Pather S; Moodley J; Ramphal S
S Afr J Surg; 2000 May; 38(1):4-6. PubMed ID: 12365118
[TBL] [Abstract][Full Text] [Related]
18. Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort.
Bozzini G; Nison L; Colin P; Ouzzane A; Yates DR; Audenet F; Pignot G; Arvin-Berod A; Merigot O; Guy L; Irani J; Saint F; Gardic S; Gres P; Rozet F; Neuzillet Y; Ruffion A; Roupret M
World J Urol; 2013 Feb; 31(1):83-91. PubMed ID: 23064982
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
20. Incidence, management, and sequelae of ureteric obstruction in women with cervical cancer.
Maguire PJ; Sobota A; Mulholland D; Ryan JM; Gleeson N
Support Care Cancer; 2020 Feb; 28(2):725-730. PubMed ID: 31129761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]